Thermo Fisher Scientific, The Cigna Group, and Tempus AI are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares of publicly traded companies in the healthcare sector that produce and sell medical products, equipment, or services. These stocks can include companies involved in pharmaceuticals, medical devices, healthcare facilities, healthcare providers, and other related businesses in the medical industry. Investors may choose to invest in medical stocks to gain exposure to the growing healthcare market and potentially benefit from the sector’s performance. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
NYSE TMO traded up $39.27 during trading on Thursday, reaching $607.50. 1,663,871 shares of the company traded hands, compared to its average volume of 2,022,212. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.26 and a current ratio of 1.63. The stock’s 50 day moving average price is $537.83 and its two-hundred day moving average price is $570.33. The company has a market cap of $232.37 billion, a price-to-earnings ratio of 38.08, a P/E/G ratio of 3.82 and a beta of 0.76. Thermo Fisher Scientific has a 1-year low of $493.30 and a 1-year high of $627.88.
Read Our Latest Research Report on TMO
The Cigna Group (CI)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Shares of NYSE:CI traded down $25.65 during trading on Thursday, reaching $277.67. The stock had a trading volume of 3,091,220 shares, compared to its average volume of 1,652,382. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The business’s 50-day moving average price is $296.05 and its 200 day moving average price is $324.99. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72. The stock has a market capitalization of $77.23 billion, a PE ratio of 26.20, a P/E/G ratio of 0.78 and a beta of 0.54.
Read Our Latest Research Report on CI
Tempus AI (TEM)
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Shares of NASDAQ:TEM traded up $6.06 during trading on Thursday, reaching $56.83. The stock had a trading volume of 13,016,511 shares, compared to its average volume of 9,698,454. Tempus AI has a 52 week low of $22.89 and a 52 week high of $79.49. The business’s 50-day moving average price is $44.11 and its 200 day moving average price is $47.97. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.
Read Our Latest Research Report on TEM
See Also
- MarketBeat’s Top Five Stocks to Own in January 2025
- How Value Investors Find Undervalued Stocks and Build Wealth
- Is Tonix Pharmaceuticals the Next Biotech Breakout?
- DeepSeek Dip: Is the Nuclear Energy Sell-Off a Buying Opportunity
- ASML: Strengths and Upside Remain Despite DeepSeek Worries
- Royal Caribbean Soars, But Smooth Sailing Isn’t Guaranteed